What is Pulse Biosciences, Inc.'s EBITDA margin?

Pulse Biosciences, Inc. (PLSE) reported EBITDA margin of -10,252.7% in Q1 2026.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Pulse Biosciences, Inc. PLSE EBITDA margin

EBITDA margin at other companies

AbbottABT

24.1%-0.2pp

Johnson & JohnsonJNJ

34.4%+2.7pp

Boston ScientificBSX

25.2%+1.6pp

MedtronicMDT

25.9%-0.4pp

Merit Medical SystemsMMSI

20.2%+0.9pp

ITG

Integer HoldingsITGR

18.3%-0.8pp

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

ebitda/total revenue=-10,252.7%

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s EBITDA margin?: Pulse Biosciences, Inc. (PLSE) reported EBITDA margin of -10,252.7% in Q1 2026.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.